Part X. Potential Role of Endogenous Opioids in Schizophrenia and Affective Disorders: DEPRESSIVE PHENOMENOLOGY AND LEVELS OF CEREBROSPINAL FLUID ENDORPHINS*
- 16 December 1982
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 398 (1) , 388-398
- https://doi.org/10.1111/j.1749-6632.1982.tb39510.x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin.Proceedings of the National Academy of Sciences, 1981
- Chemical characteristics of endorphins in human cerebrospinal fluidFEBS Letters, 1980
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979
- Analgesia to painful stimuli in affective illnessAmerican Journal of Psychiatry, 1979
- Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disordersAmerican Journal of Psychiatry, 1979
- Endorphins in PsychiatryArchives of General Psychiatry, 1978
- A Diagnostic InterviewArchives of General Psychiatry, 1978
- Naloxone (Narcan®) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolitesPsychopharmacology, 1977
- Morphine-like ligand for opiate receptors in human CSFLife Sciences, 1975
- Clinical antidepressant activity of cyclazocine—a narcotic antagonistClinical Pharmacology & Therapeutics, 1970